- the only agency authorized to declare a pandemic -- is yet to confirm that the world has entered the COVID-19 endemic ...
President Joko Widodo has said that he is impressed by the pharmaceutical industry, which has pursued the development ...
Main researcher of the Merah Putih Vaccine clinical trial at Airlangga University, (Unair) Surabaya, Dr. Dominicus ...
The third phase of Merah Putih Vaccine's clinical trial is conducted in parallel with the booster trial, Merah ...
The Eijkman Institute for Molecular Biology (PRBME) is following up on and supporting the development and preparation ...
The COVID-19 pandemic has wreaked havoc globally, including in Indonesia. It has claimed many lives, increased the ...
The first phase clinical trial of the domestically-produced Merah Putih vaccine is a huge leap for independent vaccine ...
A recent announcement that the Red and White vaccine is expected to be ready for production by mid-2022 offers hope to ...
Developing the Merah Putih COVID-19 vaccine is a big challenge as no single country has experience in developing such a ...
The integration of non-ministerial government agencies and research and development units of ministries and agencies ...
Coordinating Minister for Human Development and Culture (PMK) Muhadjir Effendy urged relevant authorities to expedite ...
It is hoped that the recent merger of the Eijkman Institute for Molecular Biology with the National Research and ...
At least 114,039,438 people received the complete dose of the COVID-19 vaccination as of Saturday afternoon, an ...
The National Research and Innovation Agency (BRIN) has said it will work on developing the Merah Putih vaccine and a ...
The Eijkman Institute for Molecular Biology (PRBME) of the National Research and Innovation Agency (BRIN) has said that ...